168 related articles for article (PubMed ID: 4181510)
21. What is the antibody specificity of LATS?
Fagraeus A; Jonsson J; el-Kabir DJ
J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
[No Abstract] [Full Text] [Related]
22. Importance of auto-immune processes in thyroid disorders.
Takó J; Bános C; Földes J; Varga H
Endokrinologie; 1969; 54(1):98-102. PubMed ID: 5395314
[No Abstract] [Full Text] [Related]
23. Autoimmunity and the pathogenesis of localized thyroid autonomy (Plummer's disease).
Wiener JD; van der Gaag RD
Clin Endocrinol (Oxf); 1985 Dec; 23(6):635-42. PubMed ID: 2869844
[TBL] [Abstract][Full Text] [Related]
24. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
25. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
[TBL] [Abstract][Full Text] [Related]
26. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
[No Abstract] [Full Text] [Related]
27. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
28. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
Mori T; Kriss JP
J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
[No Abstract] [Full Text] [Related]
29. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
30. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the study of thyroid autoantibodies by indirect immunofluorescence in 317 individuals. Histopathological comparison in 102 cases].
Codaccioni JL; Depieds R; Jean R; Henry C; Lebreuil G
Ann Endocrinol (Paris); 1971; 32(1):172-82. PubMed ID: 4933677
[No Abstract] [Full Text] [Related]
32. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
[No Abstract] [Full Text] [Related]
33. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
34. Can LATS be detected by immunofluorescence?
Beall GN; Solomon DH; Doniach D; Roitt IM
J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
[No Abstract] [Full Text] [Related]
35. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
36. [Human thyroid stimulator (HTS) in thyroid diseases].
Hu ZY
Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
[No Abstract] [Full Text] [Related]
37. Autoimmune thyroid disease.
Bottazzo GF; Doniach D
Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
[No Abstract] [Full Text] [Related]
39. [Common clinical, immunological and histological characteristics of various thyroid diseases].
Pencea V; Dobrescu G; Schapira A; Zbranca-Toporaş E; Lazăr C; Chifan M; Floareş G; Pencea I
Rev Med Chir Soc Med Nat Iasi; 1971; 75(3):577-82. PubMed ID: 5170867
[No Abstract] [Full Text] [Related]
40. [Immunological mechanisms in thyrotoxicosis].
Bradistilov S
Vutr Boles; 1979; 18(2):9-16. PubMed ID: 380170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
